These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11094304)

  • 61. Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR.
    Chan PC; Wong BY; Ozcelik H; Cole DE
    Clin Chem; 1999 Aug; 45(8 Pt 1):1285-7. PubMed ID: 10430798
    [No Abstract]   [Full Text] [Related]  

  • 62. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
    Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
    Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
    [No Abstract]   [Full Text] [Related]  

  • 63. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer.
    FitzGerald MG; MacDonald DJ; Krainer M; Hoover I; O'Neil E; Unsal H; Silva-Arrieto S; Finkelstein DM; Beer-Romero P; Englert C; Sgroi DC; Smith BL; Younger JW; Garber JE; Duda RB; Mayzel KA; Isselbacher KJ; Friend SH; Haber DA
    N Engl J Med; 1996 Jan; 334(3):143-9. PubMed ID: 8531968
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
    Foulkes WD; Chappuis PO; Wong N; Brunet JS; Vesprini D; Rozen F; Yuan ZQ; Pollak MN; Kuperstein G; Narod SA; Bégin LR
    Ann Oncol; 2000 Mar; 11(3):307-13. PubMed ID: 10811497
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA).
    Apicella C; Andrews L; Hodgson SV; Fisher SA; Lewis CM; Solomon E; Tucker K; Friedlander M; Bankier A; Southey MC; Venter DJ; Hopper JL
    Breast Cancer Res; 2003; 5(6):R206-16. PubMed ID: 14580256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Ethnic aspects of hereditary breast cancer in the region of Siberia].
    Cherdyntseva NV; Pisareva LF; Ivanova AA; Panferova YV; Malinovskaya EA; Odintsova IN; Doroshenko AV; Gervas PA; Slonimskaya EM; Shivit-ool AA; Dvornichenko VV; Choinzonov YL
    Vestn Ross Akad Med Nauk; 2014; (11-12):72-9. PubMed ID: 25971130
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.
    Rosenthal E; Moyes K; Arnell C; Evans B; Wenstrup RJ
    Breast Cancer Res Treat; 2015 Jan; 149(1):223-7. PubMed ID: 25476495
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Offit K; Foulkes W; Robson ME; Wacholder S; Eng CM; Karp SE; Begg CB
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):467-73. PubMed ID: 11352856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
    Tonin P; Weber B; Offit K; Couch F; Rebbeck TR; Neuhausen S; Godwin AK; Daly M; Wagner-Costalos J; Berman D; Grana G; Fox E; Kane MF; Kolodner RD; Krainer M; Haber DA; Struewing JP; Warner E; Rosen B; Lerman C; Peshkin B; Norton L; Serova O; Foulkes WD; Garber JE
    Nat Med; 1996 Nov; 2(11):1179-83. PubMed ID: 8898735
    [No Abstract]   [Full Text] [Related]  

  • 70. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.
    Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Scott RJ; McGuffog L; Healy S; Sinilnikova OM; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Paligo M; Aretini P; ; Kantala J; Aroer B; von Wachenfeldt A; Liljegren A; Loman N; Herbst K; Kristoffersson U; Rosenquist R; Karlsson P; Stenmark-Askmalm M; Melin B; Nathanson KL; Domchek SM; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Serrano P; Osorio A; Cajal TR; Tsitlaidou M; Benítez J; Gilbert M; ; Rookus M; Aalfs CM; Kluijt I; Boessenkool-Pape JL; Meijers-Heijboer HE; Oosterwijk JC; van Asperen CJ; Blok MJ; Nelen MR; van den Ouweland AM; Seynaeve C; van der Luijt RB; Devilee P; ; Easton DF; Peock S; Frost D; Platte R; Ellis SD; Fineberg E; Evans DG; Lalloo F; Eeles R; Jacobs C; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Godwin A; Bove B; ; Stoppa-Lyonnet D; Caux-Moncoutier V; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Boutry-Kryza N; Pujol P; Coupier I; Peyrat JP; Vennin P; Muller D; Fricker JP; Venat-Bouvet L; Johannsson OT; Isaacs C; Schmutzler R; Wappenschmidt B; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Preisler-Adams S; Simard J; Soucy P; Durocher F; Chenevix-Trench G; Beesley J; Chen X; ; Rebbeck T; Couch F; Wang X; Lindor N; Fredericksen Z; Pankratz VS; Peterlongo P; Bonanni B; Fortuzzi S; Peissel B; Szabo C; Mai PL; Loud JT; Lubinski J;
    Br J Cancer; 2012 Jun; 106(12):2016-24. PubMed ID: 22669161
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
    Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
    Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
    Ramus SJ; Friedman LS; Gayther SA; Ponder BA; Bobrow L; van der Looji M; Papp J; Olah E
    Nat Genet; 1997 Jan; 15(1):14-5. PubMed ID: 8988162
    [No Abstract]   [Full Text] [Related]  

  • 73. Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
    Hamel N; Kotar K; Foulkes WD
    BMC Med Genet; 2003 Aug; 4():7. PubMed ID: 12911837
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families.
    Friedman LS; Szabo CI; Ostermeyer EA; Dowd P; Butler L; Park T; Lee MK; Goode EL; Rowell SE; King MC
    Am J Hum Genet; 1995 Dec; 57(6):1284-97. PubMed ID: 8533757
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.
    Hopper JL; Jenkins MA
    Am J Hum Genet; 1999 Dec; 65(6):1771-6. PubMed ID: 10577931
    [No Abstract]   [Full Text] [Related]  

  • 76. Fifteen-year survival of invasive epithelial ovarian cancer in women with BRCA1/2 mutations - the National Israeli Study of Ovarian Cancer.
    Lavie O; Chetrit A; Novikov I; Sadetzki S;
    Gynecol Oncol; 2019 May; 153(2):320-325. PubMed ID: 30872026
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiers.
    Kaduri L; Gibs M; Hubert A; Sagi M; Heching N; Lerer I; Uziely B; Weinberg N; Abeliovich D; Peretz T
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):75-80. PubMed ID: 10428326
    [TBL] [Abstract][Full Text] [Related]  

  • 78. BRCA-associated breast cancer: absence of a characteristic immunophenotype.
    Robson M; Rajan P; Rosen PP; Gilewski T; Hirschaut Y; Pressman P; Haas B; Norton L; Offit K
    Cancer Res; 1998 May; 58(9):1839-42. PubMed ID: 9581822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel.
    Laitman Y; Borsthein RT; Stoppa-Lyonnet D; Dagan E; Castera L; Goislard M; Gershoni-Baruch R; Goldberg H; Kaufman B; Ben-Baruch N; Zidan J; Maray T; Soussan-Gutman L; Friedman E
    Breast Cancer Res Treat; 2011 Jun; 127(2):489-95. PubMed ID: 20960228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia.
    Pollak RD; Pollak A; Idelson M; Bejarano-Achache I; Doron D; Blumenfeld A
    J Am Geriatr Soc; 2000 Jun; 48(6):664-8. PubMed ID: 10855603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.